Just spoke to an HHS insider & man, Eli Lilly is going nuts with the peptide wars First of all, as we speak they are pushing the FDA to reclassify the glp-1s as biologics instead of peptides so that: 1. Compounding pharmacies can’t touch them, as they’re not allowed to dispense biologics. Only large manufacturers contracted by big pharma can produce biologics 2. They can extend the patents by 10-15 years min The FDA classifies anything under 40 amino acids a peptide, over 40 a biologic & they’re pushing extremely hard on Retatrutide Retatrutide sits at 39 amino acids, technically a peptide. But the argument they’re pushing is that certain side chains should be counted as amino acids, pushing it over the peptide threshold This strategy has precedent since pharma already used it to push fertility compounds like HCG, FSH & HMG into the biologic classification, removing them from the compounding pathway Patents expire, but the classification system doesn't